Fig. 5From: Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse modelPDDC treatment reduces glial activation in the hippocampus of PS19 mice. Representative images from WT mice (a–c), vehicle-treated PS19 mice (d–f), and PDDC-treated PS19 mice (g–i). Microglia were stained with Iba1 (red). Astrocytes were stained with GFAP (green). Nuclei shown in blue. j Quantification of Iba1 MFI. k Quantification of GFAP MFI. N = 216–232 images from 9 to 10 mice/group. Bars represent mean ± SEM. **P < 0.01, ***P < 0.001. Scale bars, 50 µm. Gamma and brightness adjusted equally for all images. One-way ANOVA with Tukey’s multiple comparisonBack to article page